Cargando…

Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature

Lupus nephritis (LN) is a major cause of morbidity and mortality among patients with systemic lupus erythematosus (SLE). However, promising emerging biomarkers pave the way toward an improved management of patients with LN. We have reviewed the literature over the past decade, and we herein summaris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palazzo, Leonardo, Lindblom, Julius, Mohan, Chandra, Parodis, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570701/ https://www.ncbi.nlm.nih.gov/pubmed/36233628 http://dx.doi.org/10.3390/jcm11195759

Ejemplares similares

Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade
por: Lindblom, Julius, et al.
Publicado: (2022)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

Prediction of prognosis and renal outcome in lupus nephritis
por: Parodis, Ioannis, et al.
Publicado: (2020)

Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
por: Parodis, Ioannis, et al.
Publicado: (2022)

Effect of Belimumab on Preventing de novo Renal Lupus Flares
por: Parodis, Ioannis, et al.
Publicado: (2023)

Antiphospholipid Antibodies in Lupus Nephritis
por: Parodis, Ioannis, et al.
Publicado: (2016)

Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis
por: Parodis, Ioannis, et al.
Publicado: (2019)

The Economic Burden of Lupus Nephritis: A Systematic Literature Review
por: Thompson, Juliette C., et al.
Publicado: (2021)

Interferon (IFN)-λ is a potential mediator in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2016)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

Current status of lupus nephritis
por: Jaryal, Ajay, et al.
Publicado: (2017)

Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020)

A Systematic Review of Interpathologist Agreement in Histologic Classification of Lupus Nephritis
por: Dasari, Shobha, et al.
Publicado: (2019)

Urine proteomic insights from the belimumab in lupus nephritis trial
por: Weeding, Emma, et al.
Publicado: (2022)

De novo lupus nephritis during treatment with belimumab
por: Parodis, Ioannis, et al.
Publicado: (2020)

Lupus Nephritis: Current Perspectives and Moving Forward
por: Lichtnekert, Julia, et al.
Publicado: (2022)

Early Changes in B and Plasma Cell Subsets and Traditional Serological Markers as Predictors of SRI-4 Response to Therapy in Systemic Lupus Erythematosus
por: Parodis, Ioannis, et al.
Publicado: (2022)

Lupus nephritis - alarmins may sound the alarm?
por: Wu, Tianfu, et al.
Publicado: (2012)

Lupus Nephritis Risk Factors and Biomarkers: An Update
por: Renaudineau, Yves, et al.
Publicado: (2023)

Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis
por: Nie, Huiyu, et al.
Publicado: (2023)

Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
por: Mok, Chi Chiu, et al.
Publicado: (2018)

Biomarkers for Lupus Nephritis: A Critical Appraisal
por: Mok, Chi Chiu
Publicado: (2010)

Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence
por: Gomez, Alvaro, et al.
Publicado: (2023)

Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver’s Seat in Their Disease Monitoring?
por: Parodis, Ioannis, et al.
Publicado: (2022)

Early B Cell and Plasma Cell Kinetics Upon Treatment Initiation Portend Flares in Systemic Lupus Erythematosus: A Post-Hoc Analysis of Three Phase III Clinical Trials of Belimumab
por: Parodis, Ioannis, et al.
Publicado: (2022)

Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
por: Soliman, Samar A., et al.
Publicado: (2022)

Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy
por: Parodis, Ioannis, et al.
Publicado: (2015)

Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis
por: Morell, María, et al.
Publicado: (2021)

Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature
por: Kazzi, Brigitte, et al.
Publicado: (2022)

Mobile health apps for systemic lupus erythematosus and lupus nephritis: a critical appraisal
por: Ramasamy, Akshara, et al.
Publicado: (2022)

Diagnostic test accuracy of novel biomarkers for lupus nephritis—An overview of systematic reviews
por: Guimarães, Juliana de Andrade Rebouças, et al.
Publicado: (2022)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

B Cell Kinetics upon Therapy Commencement for Active Extrarenal Systemic Lupus Erythematosus in Relation to Development of Renal Flares: Results from Three Phase III Clinical Trials of Belimumab
por: Parodis, Ioannis, et al.
Publicado: (2022)

The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
por: Chalmers, Samantha A., et al.
Publicado: (2022)

Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus
por: Borg, Alexander, et al.
Publicado: (2023)

Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus
por: Gomez, Alvaro, et al.
Publicado: (2021)

Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

Very delayed lupus nephritis: a report of three cases and literature review
por: Alexandre, André R, et al.
Publicado: (2018)

Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology
por: Ding, Huihua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_710uqk4qdf9r4j50cqod9h5dpn